The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis
The novel formula of spiramycin/propolis loaded chitosan (CS)/alginate (Alg) nanoparticles (NPs) was assessed for Toxoplasma gondii (T. gondii) treatment in comparison with the commercially available spiramycin regarding tissue penetration and blood brain barrier (BBB) passage. Swiss Albino mice wer...
Main Authors: | , , , , , , |
---|---|
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022
|
Subjects: | |
Online Access: | https://doaj.org/article/b5774997c43049abb0bd890315e5c70c |
id |
ftdoajarticles:oai:doaj.org/article:b5774997c43049abb0bd890315e5c70c |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:b5774997c43049abb0bd890315e5c70c 2023-05-15T15:14:49+02:00 The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis Nancy Abd-elkader Hagras Nermine Mogahed Fawzy Hussein Mogahed Eman Sheta Amira Abd-elfattah Darwish Mohamed Ali El-hawary Moaaz Tarek Hamed Bassma Hassan Elwakil 2022-03-01T00:00:00Z https://doaj.org/article/b5774997c43049abb0bd890315e5c70c EN eng Public Library of Science (PLoS) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926208/?tool=EBI https://doaj.org/toc/1935-2727 https://doaj.org/toc/1935-2735 1935-2727 1935-2735 https://doaj.org/article/b5774997c43049abb0bd890315e5c70c PLoS Neglected Tropical Diseases, Vol 16, Iss 3 (2022) Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 article 2022 ftdoajarticles 2022-12-31T03:35:33Z The novel formula of spiramycin/propolis loaded chitosan (CS)/alginate (Alg) nanoparticles (NPs) was assessed for Toxoplasma gondii (T. gondii) treatment in comparison with the commercially available spiramycin regarding tissue penetration and blood brain barrier (BBB) passage. Swiss Albino mice were inoculated intraperitoneally by 2500 tachyzoites of the virulent T. gondii RH strain. The experimental groups were treated with oral spiramycin, propolis, CS/Alg NPs, spiramycin loaded CS/Alg NPs, propolis loaded CS/Alg NPs, and spiramycin/propolis loaded CS/Alg NPs. The results demonstrated that spiramycin/propolis loaded CS/Alg NPs exerted the longest survival time with no mortality on the sacrifice day (8th) in addition to representing the highest significant parasite percent reduction of (≥96% reduction) in liver, spleen and brain designating successful tissue penetration and BBB passage. Tachyzoites treated with spiramycin/propolis loaded CS/Alg NPs demonstrated the most disfigured rapturing organism via scanning electron microscope examination along with representing an overall remarkable improvement of the histopathological pictures of liver, spleen and brain. In conclusion, spiramycin/propolis loaded CS/Alg NPs showed the uppermost efficacy in the treatment of acute murine toxoplasmosis. The safe nature and the anti-parasitic effect of each of CS, Alg, spiramycin and propolis encourage the synergistic use of spiramycin/propolis loaded CS/Alg NPs as a potent treatment for human toxoplasmosis. Author summary Toxoplasmosis is a disease that results from infection with a parasite known as Toxoplasma gondii (T. gondii). The parasite is considered to be one of the world’s most common parasites. Infection frequently occurs by eating undercooked contaminated meat, exposure to infected cat faeces, or mother-to-fetus transmission throughout pregnancy. The parasite has the ability to reach all body organs including the brain. This in turn, may lead to death specially among people with weakened immune systems and ... Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English |
topic |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Nancy Abd-elkader Hagras Nermine Mogahed Fawzy Hussein Mogahed Eman Sheta Amira Abd-elfattah Darwish Mohamed Ali El-hawary Moaaz Tarek Hamed Bassma Hassan Elwakil The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis |
topic_facet |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
description |
The novel formula of spiramycin/propolis loaded chitosan (CS)/alginate (Alg) nanoparticles (NPs) was assessed for Toxoplasma gondii (T. gondii) treatment in comparison with the commercially available spiramycin regarding tissue penetration and blood brain barrier (BBB) passage. Swiss Albino mice were inoculated intraperitoneally by 2500 tachyzoites of the virulent T. gondii RH strain. The experimental groups were treated with oral spiramycin, propolis, CS/Alg NPs, spiramycin loaded CS/Alg NPs, propolis loaded CS/Alg NPs, and spiramycin/propolis loaded CS/Alg NPs. The results demonstrated that spiramycin/propolis loaded CS/Alg NPs exerted the longest survival time with no mortality on the sacrifice day (8th) in addition to representing the highest significant parasite percent reduction of (≥96% reduction) in liver, spleen and brain designating successful tissue penetration and BBB passage. Tachyzoites treated with spiramycin/propolis loaded CS/Alg NPs demonstrated the most disfigured rapturing organism via scanning electron microscope examination along with representing an overall remarkable improvement of the histopathological pictures of liver, spleen and brain. In conclusion, spiramycin/propolis loaded CS/Alg NPs showed the uppermost efficacy in the treatment of acute murine toxoplasmosis. The safe nature and the anti-parasitic effect of each of CS, Alg, spiramycin and propolis encourage the synergistic use of spiramycin/propolis loaded CS/Alg NPs as a potent treatment for human toxoplasmosis. Author summary Toxoplasmosis is a disease that results from infection with a parasite known as Toxoplasma gondii (T. gondii). The parasite is considered to be one of the world’s most common parasites. Infection frequently occurs by eating undercooked contaminated meat, exposure to infected cat faeces, or mother-to-fetus transmission throughout pregnancy. The parasite has the ability to reach all body organs including the brain. This in turn, may lead to death specially among people with weakened immune systems and ... |
format |
Article in Journal/Newspaper |
author |
Nancy Abd-elkader Hagras Nermine Mogahed Fawzy Hussein Mogahed Eman Sheta Amira Abd-elfattah Darwish Mohamed Ali El-hawary Moaaz Tarek Hamed Bassma Hassan Elwakil |
author_facet |
Nancy Abd-elkader Hagras Nermine Mogahed Fawzy Hussein Mogahed Eman Sheta Amira Abd-elfattah Darwish Mohamed Ali El-hawary Moaaz Tarek Hamed Bassma Hassan Elwakil |
author_sort |
Nancy Abd-elkader Hagras |
title |
The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis |
title_short |
The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis |
title_full |
The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis |
title_fullStr |
The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis |
title_full_unstemmed |
The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis |
title_sort |
powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis |
publisher |
Public Library of Science (PLoS) |
publishDate |
2022 |
url |
https://doaj.org/article/b5774997c43049abb0bd890315e5c70c |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
PLoS Neglected Tropical Diseases, Vol 16, Iss 3 (2022) |
op_relation |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926208/?tool=EBI https://doaj.org/toc/1935-2727 https://doaj.org/toc/1935-2735 1935-2727 1935-2735 https://doaj.org/article/b5774997c43049abb0bd890315e5c70c |
_version_ |
1766345222674972672 |